Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1632-1637, March 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gumerlock, P. H.
Right arrow Articles by deVere White, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gumerlock, P. H.
Right arrow Articles by deVere White, R. W.

Activated ras Alleles in Human Carcinoma of the Prostate Are Rare

Paul H. Gumerlock1, Udayshankar R. Poonamallee2, Frederick J. Meyers and Ralph W. deVere White

Division of Hematology/Oncology, Department of Internal Medicine and Department of Urology, University of California Davis School of Medicine Sacramento, California 95817

Although oncogenically activated ras alleles are common in some types of human cancers, the frequency in human carcinoma of the prostate (CaP) has not previously been addressed. In this paper, we report a comprehensive screening of 19 CaPs and 3 CaP cell lines for activating point mutations in the sequences of the 12th and 61st codons of c-Ha-ras-1 and the c-Ki-ras-2 genes, as well as the 12th, 13th, and 61st codons of the c-N-ras gene. The 19 CaPs were chosen to represent a wide range of stages (B through D), Gleason scores (3 through 10), and DNA ploidy (diploid with low proliferation to nontetraploid-aneuploid). Fifteen of the tumors had been untreated prior to resection and 4 were obtained postradiation therapy. The polymerase chain reaction was used to amplify genomic DNA sequences and transcribed mRNA sequences of the ras genes prior to allele-specific oligonucleotide probe hybridization. We have detected a mutant allele with a point mutation in the second nucleotide of the 61st codon of the c-Ha-ras-1 gene in one specimen. Thus, we conclude that the activation of ras alleles is not significant in the development or progression of most CaPs.

1 Bank of America Giannini Medical Research Fellow (1989–1991). To whom requests for reprints should be addressed, at Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, 4301 X Street, Sacramento, CA 95817.

2 Robert J. Mathews Foundation Fellow (1989–1990).

Received 10/15/90. Accepted 1/ 7/91.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Gao, X. Ouyang, W. A. Banach-Petrosky, W. L. Gerald, M. M. Shen, and C. Abate-Shen
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
PNAS, September 26, 2006; 103(39): 14477 - 14482.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]


Home page
Endocr Relat CancerHome page
R. Foley, D. Hollywood, and M. Lawler
Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease
Endocr. Relat. Cancer, September 1, 2004; 11(3): 477 - 488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. E. Bakin, D. Gioeli, R. A. Sikes, E. A. Bissonette, and M. J. Weber
Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells
Cancer Res., April 15, 2003; 63(8): 1981 - 1989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wang, C.-P. Tseng, R.-C. Pong, H. Chen, J. D. McConnell, N. Navone, and J.-T. Hsieh
The Mechanism of Growth-inhibitory Effect of DOC-2/DAB2 in Prostate Cancer. CHARACTERIZATION OF A NOVEL GTPase-ACTIVATING PROTEIN ASSOCIATED WITH N-TERMINAL DOMAIN OF DOC-2/DAB2
J. Biol. Chem., April 5, 2002; 277(15): 12622 - 12631.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B.-J. Park, J.-I. Park, D.-S. Byun, J.-H. Park, and S.-G. Chi
Mitogenic Conversion of Transforming Growth Factor-{beta}1 Effect by Oncogenic Ha-Ras-induced Activation of the Mitogen-activated Protein Kinase Signaling Pathway in Human Prostate Cancer
Cancer Res., June 1, 2000; 60(11): 3031 - 3038.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-G. Chi, S.-G. Chang, S.-J. Lee, C.-H. Lee, J. I. Kim, and J.-H. Park
Elevated and Biallelic Expression of p73 Is Associated with Progression of Human Bladder Cancer
Cancer Res., June 1, 1999; 59(12): 2791 - 2793.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken
Molecular Genetics and Epidemiology of Prostate Carcinoma
Endocr. Rev., February 1, 1999; 20(1): 22 - 45.
[Abstract] [Full Text]


Home page
ScienceHome page
E Speir, R Modali, E. Huang, M. Leon, F Shawl, T Finkel, and S. Epstein
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
Science, July 15, 1994; 265(5170): 391 - 394.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.